155 related articles for article (PubMed ID: 26238444)
1. Noninvasive renal denervation for resistant hypertension using high-intensity focused ultrasound.
Rong S; Zhu H; Liu D; Qian J; Zhou K; Zhu Q; Jiang Y; Yang G; Deng C; Zhang D; Zhou Q; Lei H; He TC; Wang Z; Huang J
Hypertension; 2015 Oct; 66(4):e22-5. PubMed ID: 26238444
[No Abstract] [Full Text] [Related]
2. Noninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a pre-clinical canine model.
Wang Q; Guo R; Rong S; Yang G; Zhu Q; Jiang Y; Deng C; Liu D; Zhou Q; Wu Q; Wang S; Qian J; Wang Q; Lei H; He TC; Wang Z; Huang J
J Am Coll Cardiol; 2013 May; 61(21):2185-92. PubMed ID: 23541964
[TBL] [Abstract][Full Text] [Related]
3. Renal sympathetic denervation for resistant hypertension in a child after aortic coarctation surgery.
Buchhorn R; Ziemer G; Jetter HM; M Borst M; Selbach J
Int J Cardiol; 2014 Apr; 172(3):e447-8. PubMed ID: 24491868
[No Abstract] [Full Text] [Related]
4. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation.
Wang Y
Int J Cardiol; 2014 Oct; 176(3):1262-3. PubMed ID: 25115259
[No Abstract] [Full Text] [Related]
5. Cochrane corner: renal denervation for resistant hypertension-a broken promise?
Bolignano D; Coppolino G
Heart; 2017 Nov; 103(22):1753-1755. PubMed ID: 28501794
[No Abstract] [Full Text] [Related]
6. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
Witkowski A; Prejbisz A; Florczak E; Kądziela J; Śliwiński P; Bieleń P; Michałowska I; Kabat M; Warchoł E; Januszewicz M; Narkiewicz K; Somers VK; Sobotka PA; Januszewicz A
Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482
[TBL] [Abstract][Full Text] [Related]
7. Transradial renal denervation for the treatment of resistant hypertension.
Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
[TBL] [Abstract][Full Text] [Related]
8. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
Symplicity HTN-1 Investigators
Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
[TBL] [Abstract][Full Text] [Related]
9. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
[TBL] [Abstract][Full Text] [Related]
10. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
[TBL] [Abstract][Full Text] [Related]
12. Catheter-based renal denervation: Back on track?
Lauder L; Ewen S; Böhm M; Mahfoud F
Eur Heart J; 2018 Dec; 39(46):4058-4059. PubMed ID: 30535015
[No Abstract] [Full Text] [Related]
13. Catheter-based renal denervation: the next chapter begins.
Mahfoud F; Schlaich M; Böhm M; Esler M; Lüscher TF
Eur Heart J; 2018 Dec; 39(47):4144-4149. PubMed ID: 30239686
[No Abstract] [Full Text] [Related]
14. Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension.
Ewen S; Mahfoud F; Linz D; Pöss J; Cremers B; Kindermann I; Laufs U; Ukena C; Böhm M
Hypertension; 2014 Apr; 63(4):839-45. PubMed ID: 24420550
[TBL] [Abstract][Full Text] [Related]
15. Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients.
Savard S; Frank M; Bobrie G; Plouin PF; Sapoval M; Azizi M
J Am Coll Cardiol; 2012 Dec; 60(23):2422-4. PubMed ID: 23141491
[No Abstract] [Full Text] [Related]
16. Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.
Papademetriou V; Rashidi AA; Tsioufis C; Doumas M
Circulation; 2014 Apr; 129(13):1440-51. PubMed ID: 24687645
[No Abstract] [Full Text] [Related]
17. Hypertension: Proof of concept for renal denervation.
Fernández-Ruiz I
Nat Rev Cardiol; 2017 Nov; 14(11):634. PubMed ID: 28905871
[No Abstract] [Full Text] [Related]
18. Renal Denervation: History and Current Status.
Lee DP
Interv Cardiol Clin; 2020 Oct; 9(4):483-488. PubMed ID: 32921372
[TBL] [Abstract][Full Text] [Related]
19. Renal denervation in hypertension: simplicity, or complexity?
Lantelme P; Courand PY; Bricca G
Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
[No Abstract] [Full Text] [Related]
20. Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease.
Kiuchi MG; Chen S; Graciano ML; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
Int J Cardiol; 2015; 190():29-31. PubMed ID: 25912114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
